Analyze Diet
Pathogens (Basel, Switzerland)2013; 2(2); 264-287; doi: 10.3390/pathogens2020264

Henipavirus infections: lessons from animal models.

Abstract: The Henipavirus genus contains two highly lethal viruses, the Hendra and Nipah viruses and one, recently discovered, apparently nonpathogenic member; Cedar virus. These three, negative-sense single-stranded RNA viruses, are hosted by fruit bats and use EphrinB2 receptors for entry into cells. The Hendra and Nipah viruses are zoonotic pathogens that emerged in the middle of 90s and have caused severe, and often fatal, neurologic and/or respiratory diseases in both humans and different animals; including spillover into equine and porcine species. Development of relevant models is critical for a better understanding of viral pathogenesis, generating new diagnostic tools, and assessing anti-viral therapeutics and vaccines. This review summarizes available data on several animal models where natural and/or experimental infection has been demonstrated; including pteroid bats, horses, pigs, cats, hamsters, guinea pigs, ferrets, and nonhuman primates. It recapitulates the principal features of viral pathogenesis in these animals and current knowledge on anti-viral immune responses. Lastly it describes the recently characterized murine animal model, which provides the possibility to use numerous and powerful tools available for mice to further decipher henipaviruses immunopathogenesis, prophylaxis, and treatment. The utility of different models to analyze important aspects of henipaviruses-induced disease in humans, potential routes of transmission, and therapeutic approaches are equally discussed.
Publication Date: 2013-04-09 PubMed ID: 25437037PubMed Central: PMC4235719DOI: 10.3390/pathogens2020264Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research is a comprehensive review of available data on animal models used to understand and combat diseases caused by lethal viruses, Hendra and Nipah, from the Henipavirus genus. These viruses primarily affect fruit bats but can also infect humans and other animals, causing severe neurologic and/or respiratory diseases.

Henipavirus

  • Belongs to the genus Henipavirus are two highly lethal viruses, Hendra and Nipah, along with an apparently nonpathogenic member, Cedar virus. These viruses are negative-sense single-stranded RNA viruses.
  • Primarily hosted by fruit bats, these viruses use EphrinB2 receptors to enter cells.
  • The Hendra and Nipah viruses are zoonotic pathogens that first emerged in the mid-90s. These have been responsible for severe, often fatal, neurologic and/or respiratory diseases in humans and different animals, including horses and pigs.

Animal Models

  • The research summarizes data on various animal models where natural and/or experimental infection has been demonstrated. This includes bats, horses, pigs, cats, hamsters, guinea pigs, ferrets, and nonhuman primates.
  • The key features of viral pathogenesis in these animals and current knowledge on anti-viral immune responses are outlined in this study.
  • Recently, a murine animal model has been characterized, which allows for the use of numerous mice-compatible tools to further study the immunopathogenesis, prophylaxis, and treatment of henipaviruses.

Implications and future directions

  • The research also discusses the utility of these animal models in understanding important aspects of henipaviruses-induced disease in humans, potential routes of transmission, and therapeutic approaches.
  • Understanding these viruses and how they interact with different species can enable scientists to develop effective diagnostic tools and treatments. Central to this endeavour is the development and use of appropriate animal models that resemble human disease as closely as possible.

Cite This Article

APA
Dhondt KP, Horvat B. (2013). Henipavirus infections: lessons from animal models. Pathogens, 2(2), 264-287. https://doi.org/10.3390/pathogens2020264

Publication

ISSN: 2076-0817
NlmUniqueID: 101596317
Country: Switzerland
Language: English
Volume: 2
Issue: 2
Pages: 264-287

Researcher Affiliations

Dhondt, Kévin P
  • International Center for Infectiology Research, INSERM U1111, CNRS UMR5308, Ecole Normale Supérieure de Lyon, University of Lyon 1, 21 Avenue T. Garnier, Lyon 69007, France. kevin.dhondt@inserm.fr.
Horvat, Branka
  • International Center for Infectiology Research, INSERM U1111, CNRS UMR5308, Ecole Normale Supérieure de Lyon, University of Lyon 1, 21 Avenue T. Garnier, Lyon 69007, France. branka.horvat@inserm.fr.

References

This article includes 95 references
  1. Eaton BT, Broder CC, Middleton D, Wang LF. Hendra and Nipah viruses: different and dangerous.. Nat Rev Microbiol 2006 Jan;4(1):23-35.
    doi: 10.1038/nrmicro1323pmc: PMC7097447pubmed: 16357858google scholar: lookup
  2. Marsh GA, Wang LF. Hendra and Nipah viruses: why are they so deadly?. Curr Opin Virol 2012 Jun;2(3):242-7.
    doi: 10.1016/j.coviro.2012.03.006pubmed: 22483665google scholar: lookup
  3. Field H, Kung N. Henipaviruses-unanswered questions of lethal zoonoses.. Curr Opin Virol 2011 Dec;1(6):658-61.
    doi: 10.1016/j.coviro.2011.10.025pubmed: 22440924google scholar: lookup
  4. Marsh GA, de Jong C, Barr JA, Tachedjian M, Smith C, Middleton D, Yu M, Todd S, Foord AJ, Haring V, Payne J, Robinson R, Broz I, Crameri G, Field HE, Wang LF. Cedar virus: a novel Henipavirus isolated from Australian bats.. PLoS Pathog 2012;8(8):e1002836.
  5. Murray K, Rogers R, Selvey L, Selleck P, Hyatt A, Gould A, Gleeson L, Hooper P, Westbury H. A novel morbillivirus pneumonia of horses and its transmission to humans.. Emerg Infect Dis 1995 Jan-Mar;1(1):31-3.
    doi: 10.3201/eid0101.950107pmc: PMC2626820pubmed: 8903153google scholar: lookup
  6. Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, Ksiazek TG, Rollin PE, Zaki SR, Shieh W, Goldsmith CS, Gubler DJ, Roehrig JT, Eaton B, Gould AR, Olson J, Field H, Daniels P, Ling AE, Peters CJ, Anderson LJ, Mahy BW. Nipah virus: a recently emergent deadly paramyxovirus.. Science 2000 May 26;288(5470):1432-5.
    doi: 10.1126/science.288.5470.1432pubmed: 10827955google scholar: lookup
  7. Wong KT, Shieh WJ, Kumar S, Norain K, Abdullah W, Guarner J, Goldsmith CS, Chua KB, Lam SK, Tan CT, Goh KJ, Chong HT, Jusoh R, Rollin PE, Ksiazek TG, Zaki SR. Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis.. Am J Pathol 2002 Dec;161(6):2153-67.
  8. Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, Ksiazek TG, Mishra A. Nipah virus-associated encephalitis outbreak, Siliguri, India.. Emerg Infect Dis 2006 Feb;12(2):235-40.
    doi: 10.3201/eid1202.051247pmc: PMC3373078pubmed: 16494748google scholar: lookup
  9. Hsu VP, Hossain MJ, Parashar UD, Ali MM, Ksiazek TG, Kuzmin I, Niezgoda M, Rupprecht C, Bresee J, Breiman RF. Nipah virus encephalitis reemergence, Bangladesh.. Emerg Infect Dis 2004 Dec;10(12):2082-7.
    doi: 10.3201/eid1012.040701pmc: PMC3323384pubmed: 15663842google scholar: lookup
  10. Stone R. Epidemiology. Breaking the chain in Bangladesh.. Science 2011 Mar 4;331(6021):1128-31.
    doi: 10.1126/science.331.6021.1128pubmed: 21385693google scholar: lookup
  11. Harcourt BH, Lowe L, Tamin A, Liu X, Bankamp B, Bowden N, Rollin PE, Comer JA, Ksiazek TG, Hossain MJ, Gurley ES, Breiman RF, Bellini WJ, Rota PA. Genetic characterization of Nipah virus, Bangladesh, 2004.. Emerg Infect Dis 2005 Oct;11(10):1594-7.
    doi: 10.3201/eid1110.050513pmc: PMC3366751pubmed: 16318702google scholar: lookup
  12. Lo MK, Lowe L, Hummel KB, Sazzad HM, Gurley ES, Hossain MJ, Luby SP, Miller DM, Comer JA, Rollin PE, Bellini WJ, Rota PA. Characterization of Nipah virus from outbreaks in Bangladesh, 2008-2010.. Emerg Infect Dis 2012 Feb;18(2):248-55.
    doi: 10.3201/eid1802.111492pmc: PMC3310473pubmed: 22304936google scholar: lookup
  13. Tan CT, Goh KJ, Wong KT, Sarji SA, Chua KB, Chew NK, Murugasu P, Loh YL, Chong HT, Tan KS, Thayaparan T, Kumar S, Jusoh MR. Relapsed and late-onset Nipah encephalitis.. Ann Neurol 2002 Jun;51(6):703-8.
    doi: 10.1002/ana.10212pubmed: 12112075google scholar: lookup
  14. Lo MK, Rota PA. The emergence of Nipah virus, a highly pathogenic paramyxovirus.. J Clin Virol 2008 Dec;43(4):396-400.
    pubmed: 18835214doi: 10.1016/j.jcv.2008.08.007google scholar: lookup
  15. Luby SP, Gurley ES, Hossain MJ. Transmission of human infection with Nipah virus.. Clin Infect Dis 2009 Dec 1;49(11):1743-8.
    doi: 10.1086/647951pmc: PMC2784122pubmed: 19886791google scholar: lookup
  16. Drexler JF, Corman VM, Müller MA, Maganga GD, Vallo P, Binger T, Gloza-Rausch F, Cottontail VM, Rasche A, Yordanov S, Seebens A, Knörnschild M, Oppong S, Adu Sarkodie Y, Pongombo C, Lukashev AN, Schmidt-Chanasit J, Stöcker A, Carneiro AJ, Erbar S, Maisner A, Fronhoffs F, Buettner R, Kalko EK, Kruppa T, Franke CR, Kallies R, Yandoko ER, Herrler G, Reusken C, Hassanin A, Krüger DH, Matthee S, Ulrich RG, Leroy EM, Drosten C. Bats host major mammalian paramyxoviruses.. Nat Commun 2012 Apr 24;3:796.
    doi: 10.1038/ncomms1796pmc: PMC3343228pubmed: 22531181google scholar: lookup
  17. Middleton DJ, Morrissy CJ, van der Heide BM, Russell GM, Braun MA, Westbury HA, Halpin K, Daniels PW. Experimental Nipah virus infection in pteropid bats (Pteropus poliocephalus).. J Comp Pathol 2007 May;136(4):266-72.
    doi: 10.1016/j.jcpa.2007.03.002pubmed: 17498518google scholar: lookup
  18. Williamson MM, Hooper PT, Selleck PW, Gleeson LJ, Daniels PW, Westbury HA, Murray PK. Transmission studies of Hendra virus (equine morbillivirus) in fruit bats, horses and cats.. Aust Vet J 1998 Dec;76(12):813-8.
  19. Halpin K, Hyatt AD, Fogarty R, Middleton D, Bingham J, Epstein JH, Rahman SA, Hughes T, Smith C, Field HE, Daszak P. Pteropid bats are confirmed as the reservoir hosts of henipaviruses: a comprehensive experimental study of virus transmission.. Am J Trop Med Hyg 2011 Nov;85(5):946-51.
    doi: 10.4269/ajtmh.2011.10-0567pmc: PMC3205647pubmed: 22049055google scholar: lookup
  20. Mohd Nor MN, Gan CH, Ong BL. Nipah virus infection of pigs in peninsular Malaysia.. Rev Sci Tech 2000 Apr;19(1):160-5.
    pubmed: 11189713doi: 10.20506/rst.19.1.1202google scholar: lookup
  21. Middleton DJ, Westbury HA, Morrissy CJ, van der Heide BM, Russell GM, Braun MA, Hyatt AD. Experimental Nipah virus infection in pigs and cats.. J Comp Pathol 2002 Feb-Apr;126(2-3):124-36.
    doi: 10.1053/jcpa.2001.0532pubmed: 11945001google scholar: lookup
  22. Weingartl HM, Berhane Y, Caswell JL, Loosmore S, Audonnet JC, Roth JA, Czub M. Recombinant nipah virus vaccines protect pigs against challenge.. J Virol 2006 Aug;80(16):7929-38.
    pmc: PMC1563797pubmed: 16873250doi: 10.1128/jvi.00263-06google scholar: lookup
  23. Weingartl H, Czub S, Copps J, Berhane Y, Middleton D, Marszal P, Gren J, Smith G, Ganske S, Manning L, Czub M. Invasion of the central nervous system in a porcine host by nipah virus.. J Virol 2005 Jun;79(12):7528-34.
  24. Berhane Y, Weingartl HM, Lopez J, Neufeld J, Czub S, Embury-Hyatt C, Goolia M, Copps J, Czub M. Bacterial infections in pigs experimentally infected with Nipah virus.. Transbound Emerg Dis 2008 May;55(3-4):165-74.
  25. Li M, Embury-Hyatt C, Weingartl HM. Experimental inoculation study indicates swine as a potential host for Hendra virus.. Vet Res 2010 May-Jun;41(3):33.
    doi: 10.1051/vetres/2010005pmc: PMC2826093pubmed: 20167195google scholar: lookup
  26. Hooper P, Zaki S, Daniels P, Middleton D. Comparative pathology of the diseases caused by Hendra and Nipah viruses.. Microbes Infect 2001 Apr;3(4):315-22.
    doi: 10.1016/S1286-4579(01)01385-5pubmed: 11334749google scholar: lookup
  27. Marsh GA, Haining J, Hancock TJ, Robinson R, Foord AJ, Barr JA, Riddell S, Heine HG, White JR, Crameri G, Field HE, Wang LF, Middleton D. Experimental infection of horses with Hendra virus/Australia/horse/2008/Redlands.. Emerg Infect Dis 2011 Dec;17(12):2232-8.
    pmc: PMC3311212pubmed: 22172152doi: 10.3201/eid1712.111162google scholar: lookup
  28. Rogers RJ, Douglas IC, Baldock FC, Glanville RJ, Seppanen KT, Gleeson LJ, Selleck PN, Dunn KJ. Investigation of a second focus of equine morbillivirus infection in coastal Queensland.. Aust Vet J 1996 Sep;74(3):243-4.
  29. Mungall BA, Middleton D, Crameri G, Bingham J, Halpin K, Russell G, Green D, McEachern J, Pritchard LI, Eaton BT, Wang LF, Bossart KN, Broder CC. Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine.. J Virol 2006 Dec;80(24):12293-302.
    pmc: PMC1676295pubmed: 17005664doi: 10.1128/jvi.01619-06google scholar: lookup
  30. Mungall BA, Middleton D, Crameri G, Halpin K, Bingham J, Eaton BT, Broder CC. Vertical transmission and fetal replication of Nipah virus in an experimentally infected cat.. J Infect Dis 2007 Sep 15;196(6):812-6.
    doi: 10.1086/520818pubmed: 17703410google scholar: lookup
  31. McEachern JA, Bingham J, Crameri G, Green DJ, Hancock TJ, Middleton D, Feng YR, Broder CC, Wang LF, Bossart KN. A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats.. Vaccine 2008 Jul 23;26(31):3842-52.
  32. Westbury HA, Hooper PT, Selleck PW, Murray PK. Equine morbillivirus pneumonia: susceptibility of laboratory animals to the virus.. Aust Vet J 1995 Jul;72(7):278-9.
  33. Westbury HA, Hooper PT, Brouwer SL, Selleck PW. Susceptibility of cats to equine morbillivirus.. Aust Vet J 1996 Aug;74(2):132-4.
  34. Hooper PT, Westbury HA, Russell GM. The lesions of experimental equine morbillivirus disease in cats and guinea pigs.. Vet Pathol 1997 Jul;34(4):323-9.
    doi: 10.1177/030098589703400408pubmed: 9240841google scholar: lookup
  35. Clayton BA, Middleton D, Bergfeld J, Haining J, Arkinstall R, Wang L, Marsh GA. Transmission routes for nipah virus from Malaysia and Bangladesh.. Emerg Infect Dis 2012 Dec;18(12):1983-93.
    doi: 10.3201/eid1812.120875pmc: PMC3557903pubmed: 23171621google scholar: lookup
  36. Bossart KN, Bingham J, Middleton D. Targeted strategies for henipavirus therapeutics.. Open Virol J 2007;1:14-25.
    pmc: PMC2675550pubmed: 19440455doi: 10.2174/1874357900701010014google scholar: lookup
  37. Pallister J, Middleton D, Crameri G, Yamada M, Klein R, Hancock TJ, Foord A, Shiell B, Michalski W, Broder CC, Wang LF. Chloroquine administration does not prevent Nipah virus infection and disease in ferrets.. J Virol 2009 Nov;83(22):11979-82.
    doi: 10.1128/JVI.01847-09pmc: PMC2772715pubmed: 19759137google scholar: lookup
  38. Bossart KN, Zhu Z, Middleton D, Klippel J, Crameri G, Bingham J, McEachern JA, Green D, Hancock TJ, Chan YP, Hickey AC, Dimitrov DS, Wang LF, Broder CC. A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.. PLoS Pathog 2009 Oct;5(10):e1000642.
  39. Pallister J, Middleton D, Wang LF, Klein R, Haining J, Robinson R, Yamada M, White J, Payne J, Feng YR, Chan YP, Broder CC. A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge.. Vaccine 2011 Aug 5;29(34):5623-30.
  40. Marianneau P, Guillaume V, Wong T, Badmanathan M, Looi RY, Murri S, Loth P, Tordo N, Wild F, Horvat B, Contamin H. Experimental infection of squirrel monkeys with nipah virus.. Emerg Infect Dis 2010 Mar;16(3):507-10.
    pmc: PMC3322034pubmed: 20202432doi: 10.3201/eid1603.091346google scholar: lookup
  41. Geisbert TW, Daddario-DiCaprio KM, Hickey AC, Smith MA, Chan YP, Wang LF, Mattapallil JJ, Geisbert JB, Bossart KN, Broder CC. Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection.. PLoS One 2010 May 18;5(5):e10690.
  42. Bossart KN, Rockx B, Feldmann F, Brining D, Scott D, LaCasse R, Geisbert JB, Feng YR, Chan YP, Hickey AC, Broder CC, Feldmann H, Geisbert TW. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.. Sci Transl Med 2012 Aug 8;4(146):146ra107.
  43. Rockx B, Bossart KN, Feldmann F, Geisbert JB, Hickey AC, Brining D, Callison J, Safronetz D, Marzi A, Kercher L, Long D, Broder CC, Feldmann H, Geisbert TW. A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment.. J Virol 2010 Oct;84(19):9831-9.
    doi: 10.1128/JVI.01163-10pmc: PMC2937751pubmed: 20660198google scholar: lookup
  44. Bossart KN, Geisbert TW, Feldmann H, Zhu Z, Feldmann F, Geisbert JB, Yan L, Feng YR, Brining D, Scott D, Wang Y, Dimitrov AS, Callison J, Chan YP, Hickey AC, Dimitrov DS, Broder CC, Rockx B. A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge.. Sci Transl Med 2011 Oct 19;3(105):105ra103.
  45. Dhondt KP, Mathieu C, Chalons M, Reynaud JM, Vallve A, Raoul H, Horvat B. Type I interferon signaling protects mice from lethal henipavirus infection.. J Infect Dis 2013 Jan 1;207(1):142-51.
    pmc: PMC7107294pubmed: 23089589doi: 10.1093/infdis/jis653google scholar: lookup
  46. Dups J, Middleton D, Yamada M, Monaghan P, Long F, Robinson R, Marsh GA, Wang LF. A new model for Hendra virus encephalitis in the mouse.. PLoS One 2012;7(7):e40308.
  47. Wong KT, Grosjean I, Brisson C, Blanquier B, Fevre-Montange M, Bernard A, Loth P, Georges-Courbot MC, Chevallier M, Akaoka H, Marianneau P, Lam SK, Wild TF, Deubel V. A golden hamster model for human acute Nipah virus infection.. Am J Pathol 2003 Nov;163(5):2127-37.
  48. Rockx B, Brining D, Kramer J, Callison J, Ebihara H, Mansfield K, Feldmann H. Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection.. J Virol 2011 Aug;85(15):7658-71.
    doi: 10.1128/JVI.00473-11pmc: PMC3147900pubmed: 21593160google scholar: lookup
  49. de Wit E, Bushmaker T, Scott D, Feldmann H, Munster VJ. Nipah virus transmission in a hamster model.. PLoS Negl Trop Dis 2011 Dec;5(12):e1432.
  50. DeBuysscher BL, de Wit E, Munster VJ, Scott D, Feldmann H, Prescott J. Comparison of the pathogenicity of Nipah virus isolates from Bangladesh and Malaysia in the Syrian hamster.. PLoS Negl Trop Dis 2013;7(1):e2024.
  51. Yoneda M, Guillaume V, Sato H, Fujita K, Georges-Courbot MC, Ikeda F, Omi M, Muto-Terao Y, Wild TF, Kai C. The nonstructural proteins of Nipah virus play a key role in pathogenicity in experimentally infected animals.. PLoS One 2010 Sep 15;5(9):e12709.
  52. Mathieu C, Guillaume V, Volchkova VA, Pohl C, Jacquot F, Looi RY, Wong KT, Legras-Lachuer C, Volchkov VE, Lachuer J, Horvat B. Nonstructural Nipah virus C protein regulates both the early host proinflammatory response and viral virulence.. J Virol 2012 Oct;86(19):10766-75.
    pmc: PMC3457280pubmed: 22837207doi: 10.1128/jvi.01203-12google scholar: lookup
  53. Mathieu C, Guillaume V, Sabine A, Ong KC, Wong KT, Legras-Lachuer C, Horvat B. Lethal Nipah virus infection induces rapid overexpression of CXCL10.. PLoS One 2012;7(2):e32157.
  54. Guillaume V, Contamin H, Loth P, Georges-Courbot MC, Lefeuvre A, Marianneau P, Chua KB, Lam SK, Buckland R, Deubel V, Wild TF. Nipah virus: vaccination and passive protection studies in a hamster model.. J Virol 2004 Jan;78(2):834-40.
  55. Guillaume V, Contamin H, Loth P, Grosjean I, Courbot MC, Deubel V, Buckland R, Wild TF. Antibody prophylaxis and therapy against Nipah virus infection in hamsters.. J Virol 2006 Feb;80(4):1972-8.
  56. Freiberg AN, Worthy MN, Lee B, Holbrook MR. Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection.. J Gen Virol 2010 Mar;91(Pt 3):765-72.
    doi: 10.1099/vir.0.017269-0pmc: PMC2888097pubmed: 19889926google scholar: lookup
  57. Georges-Courbot MC, Contamin H, Faure C, Loth P, Baize S, Leyssen P, Neyts J, Deubel V. Poly(I)-poly(C12U) but not ribavirin prevents death in a hamster model of Nipah virus infection.. Antimicrob Agents Chemother 2006 May;50(5):1768-72.
  58. Ploquin A, Szécsi J, Mathieu C, Guillaume V, Barateau V, Ong KC, Wong KT, Cosset FL, Horvat B, Salvetti A. Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines.. J Infect Dis 2013 Feb 1;207(3):469-78.
    doi: 10.1093/infdis/jis699pmc: PMC7107322pubmed: 23175762google scholar: lookup
  59. Guillaume V, Wong KT, Looi RY, Georges-Courbot MC, Barrot L, Buckland R, Wild TF, Horvat B. Acute Hendra virus infection: Analysis of the pathogenesis and passive antibody protection in the hamster model.. Virology 2009 May 10;387(2):459-65.
    doi: 10.1016/j.virol.2009.03.001pubmed: 19328514google scholar: lookup
  60. Williamson MM, Hooper PT, Selleck PW, Westbury HA, Slocombe RF. A guinea-pig model of Hendra virus encephalitis.. J Comp Pathol 2001 May;124(4):273-9.
    doi: 10.1053/jcpa.2001.0464pubmed: 11437503google scholar: lookup
  61. Williamson MM, Hooper PT, Selleck PW, Westbury HA, Slocombe RF. Experimental hendra virus infectionin pregnant guinea-pigs and fruit Bats (Pteropus poliocephalus).. J Comp Pathol 2000 Feb-Apr;122(2-3):201-7.
    doi: 10.1053/jcpa.1999.0364pubmed: 10684689google scholar: lookup
  62. Calisher CH, Childs JE, Field HE, Holmes KV, Schountz T. Bats: important reservoir hosts of emerging viruses.. Clin Microbiol Rev 2006 Jul;19(3):531-45.
    doi: 10.1128/CMR.00017-06pmc: PMC1539106pubmed: 16847084google scholar: lookup
  63. Wong S, Lau S, Woo P, Yuen KY. Bats as a continuing source of emerging infections in humans.. Rev Med Virol 2007 Mar-Apr;17(2):67-91.
    doi: 10.1002/rmv.520pmc: PMC7169091pubmed: 17042030google scholar: lookup
  64. Young PL, Halpin K, Selleck PW, Field H, Gravel JL, Kelly MA, Mackenzie JS. Serologic evidence for the presence in Pteropus bats of a paramyxovirus related to equine morbillivirus.. Emerg Infect Dis 1996 Jul-Sep;2(3):239-40.
    doi: 10.3201/eid0203.960315pmc: PMC2626799pubmed: 8903239google scholar: lookup
  65. Halpin K, Young PL, Field HE, Mackenzie JS. Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus.. J Gen Virol 2000 Aug;81(Pt 8):1927-1932.
    pubmed: 10900029doi: 10.1099/0022-1317-81-8-1927google scholar: lookup
  66. Yob JM, Field H, Rashdi AM, Morrissy C, van der Heide B, Rota P, bin Adzhar A, White J, Daniels P, Jamaluddin A, Ksiazek T. Nipah virus infection in bats (order Chiroptera) in peninsular Malaysia.. Emerg Infect Dis 2001 May-Jun;7(3):439-41.
    pmc: PMC2631791pubmed: 11384522doi: 10.3201/eid0703.010312google scholar: lookup
  67. Yadav PD, Raut CG, Shete AM, Mishra AC, Towner JS, Nichol ST, Mourya DT. Detection of Nipah virus RNA in fruit bat (Pteropus giganteus) from India.. Am J Trop Med Hyg 2012 Sep;87(3):576-8.
    doi: 10.4269/ajtmh.2012.11-0416pmc: PMC3435367pubmed: 22802440google scholar: lookup
  68. Olson JG, Rupprecht C, Rollin PE, An US, Niezgoda M, Clemins T, Walston J, Ksiazek TG. Antibodies to Nipah-like virus in bats (Pteropus lylei), Cambodia.. Emerg Infect Dis 2002 Sep;8(9):987-8.
    doi: 10.3201/eid0809.010515pmc: PMC2732552pubmed: 12194780google scholar: lookup
  69. Reynes JM, Counor D, Ong S, Faure C, Seng V, Molia S, Walston J, Georges-Courbot MC, Deubel V, Sarthou JL. Nipah virus in Lyle's flying foxes, Cambodia.. Emerg Infect Dis 2005 Jul;11(7):1042-7.
    doi: 10.3201/eid1107.041350pmc: PMC3371782pubmed: 16022778google scholar: lookup
  70. Sendow I, Field HE, Curran J, Darminto, Morrissy C, Meehan G, Buick T, Daniels P. Henipavirus in Pteropus vampyrus bats, Indonesia.. Emerg Infect Dis 2006 Apr;12(4):711-2.
    doi: 10.3201/eid1204.051181pmc: PMC3294701pubmed: 16715584google scholar: lookup
  71. Wacharapluesadee S, Boongird K, Wanghongsa S, Ratanasetyuth N, Supavonwong P, Saengsen D, Gongal GN, Hemachudha T. A longitudinal study of the prevalence of Nipah virus in Pteropus lylei bats in Thailand: evidence for seasonal preference in disease transmission.. Vector Borne Zoonotic Dis 2010 Mar;10(2):183-90.
    doi: 10.1089/vbz.2008.0105pubmed: 19402762google scholar: lookup
  72. Li Y, Wang J, Hickey AC, Zhang Y, Li Y, Wu Y, Zhang H, Yuan J, Han Z, McEachern J, Broder CC, Wang LF, Shi Z. Antibodies to Nipah or Nipah-like viruses in bats, China.. Emerg Infect Dis 2008 Dec;14(12):1974-6.
    doi: 10.3201/eid1412.080359pmc: PMC2634619pubmed: 19046545google scholar: lookup
  73. Clayton BA, Wang LF, Marsh GA. Henipaviruses: an updated review focusing on the pteropid reservoir and features of transmission.. Zoonoses Public Health 2013 Feb;60(1):69-83.
  74. Chua KB, Koh CL, Hooi PS, Wee KF, Khong JH, Chua BH, Chan YP, Lim ME, Lam SK. Isolation of Nipah virus from Malaysian Island flying-foxes.. Microbes Infect 2002 Feb;4(2):145-51.
    doi: 10.1016/S1286-4579(01)01522-2pubmed: 11880045google scholar: lookup
  75. Sohayati AR, Hassan L, Sharifah SH, Lazarus K, Zaini CM, Epstein JH, Shamsyul Naim N, Field HE, Arshad SS, Abdul Aziz J, Daszak P. Evidence for Nipah virus recrudescence and serological patterns of captive Pteropus vampyrus.. Epidemiol Infect 2011 Oct;139(10):1570-9.
    pmc: PMC3423900pubmed: 21524339doi: 10.1017/s0950268811000550google scholar: lookup
  76. Bossart KN, Tachedjian M, McEachern JA, Crameri G, Zhu Z, Dimitrov DS, Broder CC, Wang LF. Functional studies of host-specific ephrin-B ligands as Henipavirus receptors.. Virology 2008 Mar 15;372(2):357-71.
    doi: 10.1016/j.virol.2007.11.011pubmed: 18054977google scholar: lookup
  77. Negrete OA, Chu D, Aguilar HC, Lee B. Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage.. J Virol 2007 Oct;81(19):10804-14.
    doi: 10.1128/JVI.00999-07pmc: PMC2045465pubmed: 17652392google scholar: lookup
  78. Field H, Young P, Yob JM, Mills J, Hall L, Mackenzie J. The natural history of Hendra and Nipah viruses.. Microbes Infect 2001 Apr;3(4):307-14.
    doi: 10.1016/S1286-4579(01)01384-3pubmed: 11334748google scholar: lookup
  79. Chua KB. Nipah virus outbreak in Malaysia.. J Clin Virol 2003 Apr;26(3):265-75.
    doi: 10.1016/S1386-6532(02)00268-8pubmed: 12637075google scholar: lookup
  80. Epstein JH, Abdul Rahman S, Zambriski JA, Halpin K, Meehan G, Jamaluddin AA, Hassan SS, Field HE, Hyatt AD, Daszak P. Feral cats and risk for Nipah virus transmission.. Emerg Infect Dis 2006 Jul;12(7):1178-9.
    doi: 10.3201/eid1207.050799pmc: PMC3291044pubmed: 16848051google scholar: lookup
  81. Mills JN, Alim AN, Bunning ML, Lee OB, Wagoner KD, Amman BR, Stockton PC, Ksiazek TG. Nipah virus infection in dogs, Malaysia, 1999.. Emerg Infect Dis 2009 Jun;15(6):950-2.
    doi: 10.3201/eid1506.080453pmc: PMC2727347pubmed: 19523300google scholar: lookup
  82. . Hendra virus, equine - Australia (21): (QL) canine. ProMed Mail. 2011. [(access on 4 April 2013)]. Archive Number: 20110802.2324. Available online: http://www.promedmail.org/
  83. Hayman DT, Wang LF, Barr J, Baker KS, Suu-Ire R, Broder CC, Cunningham AA, Wood JL. Antibodies to henipavirus or henipa-like viruses in domestic pigs in Ghana, West Africa.. PLoS One 2011;6(9):e25256.
  84. Mathieu C, Pohl C, Szecsi J, Trajkovic-Bodennec S, Devergnas S, Raoul H, Cosset FL, Gerlier D, Wild TF, Horvat B. Nipah virus uses leukocytes for efficient dissemination within a host.. J Virol 2011 Aug;85(15):7863-71.
    pmc: PMC3147937pubmed: 21593145doi: 10.1128/jvi.00549-11google scholar: lookup
  85. Stachowiak B, Weingartl HM. Nipah virus infects specific subsets of porcine peripheral blood mononuclear cells.. PLoS One 2012;7(1):e30855.
  86. Field H, Schaaf K, Kung N, Simon C, Waltisbuhl D, Hobert H, Moore F, Middleton D, Crook A, Smith G, Daniels P, Glanville R, Lovell D. Hendra virus outbreak with novel clinical features, Australia.. Emerg Infect Dis 2010 Feb;16(2):338-40.
    doi: 10.3201/eid1602.090780pmc: PMC2958006pubmed: 20113576google scholar: lookup
  87. Westbury HA. Hendra virus disease in horses.. Rev Sci Tech 2000 Apr;19(1):151-9.
    pubmed: 11189712doi: 10.20506/rst.19.1.1203google scholar: lookup
  88. Parashar UD, Sunn LM, Ong F, Mounts AW, Arif MT, Ksiazek TG, Kamaluddin MA, Mustafa AN, Kaur H, Ding LM, Othman G, Radzi HM, Kitsutani PT, Stockton PC, Arokiasamy J, Gary HE Jr, Anderson LJ. Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia.. J Infect Dis 2000 May;181(5):1755-9.
    doi: 10.1086/315457pubmed: 10823779google scholar: lookup
  89. Munster VJ, Prescott JB, Bushmaker T, Long D, Rosenke R, Thomas T, Scott D, Fischer ER, Feldmann H, de Wit E. Rapid Nipah virus entry into the central nervous system of hamsters via the olfactory route.. Sci Rep 2012;2:736.
    pmc: PMC3471094pubmed: 23071900doi: 10.1038/srep00736google scholar: lookup
  90. Lo MK, Miller D, Aljofan M, Mungall BA, Rollin PE, Bellini WJ, Rota PA. Characterization of the antiviral and inflammatory responses against Nipah virus in endothelial cells and neurons.. Virology 2010 Aug 15;404(1):78-88.
    doi: 10.1016/j.virol.2010.05.005pubmed: 20552729google scholar: lookup
  91. Torres-Velez FJ, Shieh WJ, Rollin PE, Morken T, Brown C, Ksiazek TG, Zaki SR. Histopathologic and immunohistochemical characterization of Nipah virus infection in the guinea pig.. Vet Pathol 2008 Jul;45(4):576-85.
    doi: 10.1354/vp.45-4-576pubmed: 18587107google scholar: lookup
  92. Blackman MA, Woodland DL. The narrowing of the CD8 T cell repertoire in old age.. Curr Opin Immunol 2011 Aug;23(4):537-42.
    doi: 10.1016/j.coi.2011.05.005pmc: PMC3163762pubmed: 21652194google scholar: lookup
  93. Frasca D, Blomberg BB. Aging impairs murine B cell differentiation and function in primary and secondary lymphoid tissues.. Aging Dis 2011 Oct;2(5):361-73.
    pmc: PMC3295082pubmed: 22396888
  94. Kovacs EJ, Palmer JL, Fortin CF, Fülöp T Jr, Goldstein DR, Linton PJ. Aging and innate immunity in the mouse: impact of intrinsic and extrinsic factors.. Trends Immunol 2009 Jul;30(7):319-24.
    doi: 10.1016/j.it.2009.03.012pmc: PMC2898122pubmed: 19541536google scholar: lookup
  95. Müller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. Functional role of type I and type II interferons in antiviral defense.. Science 1994 Jun 24;264(5167):1918-21.
    pubmed: 8009221doi: 10.1126/science.8009221google scholar: lookup

Citations

This article has been cited 19 times.
  1. Findlay-Wilson S, Flett L, Salguero FJ, Ruedas-Torres I, Fotheringham S, Easterbrook L, Graham V, Dowall S. Establishment of a Nipah Virus Disease Model in Hamsters, including a Comparison of Intranasal and Intraperitoneal Routes of Challenge.. Pathogens 2023 Jul 26;12(8).
    doi: 10.3390/pathogens12080976pubmed: 37623936google scholar: lookup
  2. Juelich T, Smith J, Freiberg AN. Syrian Golden Hamster Model for Nipah Virus Infection.. Methods Mol Biol 2023;2682:219-229.
    doi: 10.1007/978-1-0716-3283-3_16pubmed: 37610585google scholar: lookup
  3. Welch SR, Spengler JR, Genzer SC, Coleman-McCray JD, Harmon JR, Sorvillo TE, Scholte FEM, Rodriguez SE, O'Neal TJ, Ritter JM, Ficarra G, Davies KA, Kainulainen MH, Karaaslan E, Bergeron É, Goldsmith CS, Lo MK, Nichol ST, Montgomery JM, Spiropoulou CF. Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination.. Sci Adv 2023 Aug 4;9(31):eadh4057.
    doi: 10.1126/sciadv.adh4057pubmed: 37540755google scholar: lookup
  4. Escudero-Pérez B, Lalande A, Mathieu C, Lawrence P. Host-Pathogen Interactions Influencing Zoonotic Spillover Potential and Transmission in Humans.. Viruses 2023 Feb 22;15(3).
    doi: 10.3390/v15030599pubmed: 36992308google scholar: lookup
  5. Forero C, Ritter JM, Seixas JN, Coleman-McCray JD, Brake M, Condrey JA, Tansey C, Welch SR, Genzer SC, Spengler JR. Volume-Associated Clinical and Histopathological Effects of Intranasal Instillation in Syrian Hamsters: Considerations for Infection and Therapeutic Studies.. Pathogens 2022 Aug 10;11(8).
    doi: 10.3390/pathogens11080898pubmed: 36015019google scholar: lookup
  6. Lawrence P, Escudero-Pérez B. Henipavirus Immune Evasion and Pathogenesis Mechanisms: Lessons Learnt from Natural Infection and Animal Models.. Viruses 2022 Apr 29;14(5).
    doi: 10.3390/v14050936pubmed: 35632678google scholar: lookup
  7. Loomis RJ, DiPiazza AT, Falcone S, Ruckwardt TJ, Morabito KM, Abiona OM, Chang LA, Caringal RT, Presnyak V, Narayanan E, Tsybovsky Y, Nair D, Hutchinson GB, Stewart-Jones GBE, Kueltzo LA, Himansu S, Mascola JR, Carfi A, Graham BS. Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine.. Front Immunol 2021;12:772864.
    doi: 10.3389/fimmu.2021.772864pubmed: 34956199google scholar: lookup
  8. Platto S, Zhou J, Wang Y, Wang H, Carafoli E. Biodiversity loss and COVID-19 pandemic: The role of bats in the origin and the spreading of the disease.. Biochem Biophys Res Commun 2021 Jan 29;538:2-13.
    doi: 10.1016/j.bbrc.2020.10.028pubmed: 33092787google scholar: lookup
  9. Jakhmola S, Indari O, Chatterjee S, Jha HC. SARS-CoV-2, an Underestimated Pathogen of the Nervous System.. SN Compr Clin Med 2020;2(11):2137-2146.
    doi: 10.1007/s42399-020-00522-7pubmed: 33015550google scholar: lookup
  10. Amaya M, Broder CC. Vaccines to Emerging Viruses: Nipah and Hendra.. Annu Rev Virol 2020 Sep 29;7(1):447-473.
  11. Kalodimou G, Veit S, Jany S, Kalinke U, Broder CC, Sutter G, Volz A. A Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia Virus MVA Activates Specific CD8 and CD4 T Cells in Mice.. Viruses 2019 Dec 24;12(1).
    doi: 10.3390/v12010026pubmed: 31878180google scholar: lookup
  12. Pelissier R, Iampietro M, Horvat B. Recent advances in the understanding of Nipah virus immunopathogenesis and anti-viral approaches.. F1000Res 2019;8.
  13. Bradel-Tretheway BG, Zamora JLR, Stone JA, Liu Q, Li J, Aguilar HC. Nipah and Hendra Virus Glycoproteins Induce Comparable Homologous but Distinct Heterologous Fusion Phenotypes.. J Virol 2019 Jul 1;93(13).
    doi: 10.1128/JVI.00577-19pubmed: 30971473google scholar: lookup
  14. Wong ACP, Li X, Lau SKP, Woo PCY. Global Epidemiology of Bat Coronaviruses.. Viruses 2019 Feb 20;11(2).
    doi: 10.3390/v11020174pubmed: 30791586google scholar: lookup
  15. Leon AJ, Borisevich V, Boroumand N, Seymour R, Nusbaum R, Escaffre O, Xu L, Kelvin DJ, Rockx B. Host gene expression profiles in ferrets infected with genetically distinct henipavirus strains.. PLoS Negl Trop Dis 2018 Mar;12(3):e0006343.
    doi: 10.1371/journal.pntd.0006343pubmed: 29538374google scholar: lookup
  16. Guillaume-Vasselin V, Lemaitre L, Dhondt KP, Tedeschi L, Poulard A, Charreyre C, Horvat B. Protection from Hendra virus infection with Canarypox recombinant vaccine.. NPJ Vaccines 2016;1:16003.
    doi: 10.1038/npjvaccines.2016.3pubmed: 29263849google scholar: lookup
  17. Cong Y, Lentz MR, Lara A, Alexander I, Bartos C, Bohannon JK, Hammoud D, Huzella L, Jahrling PB, Janosko K, Jett C, Kollins E, Lackemeyer M, Mollura D, Ragland D, Rojas O, Solomon J, Xu Z, Munster V, Holbrook MR. Loss in lung volume and changes in the immune response demonstrate disease progression in African green monkeys infected by small-particle aerosol and intratracheal exposure to Nipah virus.. PLoS Negl Trop Dis 2017 Apr;11(4):e0005532.
    doi: 10.1371/journal.pntd.0005532pubmed: 28388650google scholar: lookup
  18. Broder CC, Weir DL, Reid PA. Hendra virus and Nipah virus animal vaccines.. Vaccine 2016 Jun 24;34(30):3525-34.
    doi: 10.1016/j.vaccine.2016.03.075pubmed: 27154393google scholar: lookup
  19. Renukaradhya GJ, Narasimhan B, Mallapragada SK. Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation.. J Control Release 2015 Dec 10;219:622-631.
    doi: 10.1016/j.jconrel.2015.09.047pubmed: 26410807google scholar: lookup